Huons Co., Ltd. (KOSDAQ:243070)

South Korea flag South Korea · Delayed Price · Currency is KRW
28,600
-150 (-0.52%)
At close: Feb 27, 2026
10.00%
Market Cap 333.24B
Revenue (ttm) 602.21B
Net Income (ttm) 35.75B
Shares Out 11.65M
EPS (ttm) 2,985.83
PE Ratio 9.58
Forward PE n/a
Dividend 920.00 (3.22%)
Ex-Dividend Date Apr 2, 2026
Volume 35,160
Average Volume 27,862
Open 28,700
Previous Close 28,750
Day's Range 28,300 - 29,000
52-Week Range 23,100 - 32,200
Beta 0.04
RSI 56.89
Earnings Date Feb 12, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic... [Read more]

Sector Healthcare
Founded 1965
Employees 912
Stock Exchange KOSDAQ
Ticker Symbol 243070
Full Company Profile

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.

Financial Statements

News

There is no news available yet.